Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How zombie companies like Venturis Therapeutics die
Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) has for all practical purposes been dead since 2008. But like a good zombie company, it has continued onwards pointlessly for another 13 years, trying to give every impression of viability where there is none. Zzzombie….zzzombie….zzzzzzombie…….zzzzzzzzzzzzz.........
But even zombie companies like Venturis Therapeutics eventually die. And that death for Venturis is at hand, now that Venturis has suffered a crushing 7-figure judgment it reportedly can’t pay. Further, Venturis is facing a winning adversary that is rumored to be planning very aggressive collection efforts. Once the final judgment amount is announced by the judge arbitrator, the collection effort is likely to immediately commence.
The only question unclear to me is whether or not Venturis’s death will come from involuntary bankruptcy and liquidation, or if Venturis will file for bankruptcy itself in the onslaught of collection activities and then be liquidated (there is no revenue stream here, so liquidation is certain). One fact is clear to me: Venturis will not be able to pay the judgment. The company has been insolvent for over a decade, and according to a particular insider who left the company and spoke candidly with a shareholder who reached out to him/her, Venturis/CVBT has been out of cash for years (i.e. illiquid) and is unable to advance on anything meaningful or costly (patents are cheap, and in this case, pointless). All the absurd chatter here indicating that Venturis Therapeutics or CVBT has raised $10 million, $150 million, $2 billion, or whatever fictional number suits the moment, based on valuations that exceed Apple’s or whatever nonsense is being spouted, is pure fantasy with a strong alcoholic delusional component. Let's face it, no one is going to invest a dime in a company that's led by an accused crook who's alleged by the U.S. governement to have stolen $14 million from his previous company, and who has repeated accusations of fraud hovering around companies he's been involved with, more than a few of which have ended up in bankruptcy. I'm referring of course to Calvin Wallen III. Venturis has provided zero evidence that any money has come in—-because it didn’t as best anyone can tell. Indeed, CFO Robert Schleizer said at one of the annual shareholder meetings that the company had received a qualified audit from its auditors with a going concern disclaimer. Do you know what that’s called in accounting circles? The death spiral. Companies rarely recover from it. And this one won’t.
So long, farewell, auf wiedersehen, goodbye...
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
And to hear more from a Venturis insider who spilled the beans:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
Grant Gordon, as one of the leaders of Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT), don't you know that arguing both sides of an issue under different fake identities not only fools no one, but also suggests late-stage alcoholic dementia? Look it up, it's a symptom which is not rare in patients with alcohol-induced end-stage liver disease.
I saw this valuation too. It was done by Madoff Securities. And the independent auditor's letter was from Arthur Andersen.
Important Clarification
I should clarify something from my previous message. I don't believe Grant Gordon has anything to be embarrased about by his lack of education. It's wrong of me to suggest that not having even a high school diploma is in any way a mark of shame.
The fact is, Grant has a junior high school/middle school diploma. For sure there are people out there who can't say even that. Grant Gordon should wear his middle school/junior high school diploma with pride, in my opinion.
As a great philosopher once said: "Own it, baby!"
Venturis is unable to acknowledge its horrific missteps. Instead all we get from this company and its supporters (i.e. company management putting out information not under their own names) is deflection, finger-pointing, false statements, and constantly looking backward and blaming someone who left 7 years ago. Isn't that pathetic - to only be blaming someone who hasn't been inside the company in 7 years? It shows a remarkable lack of accountability, honesty, integrity, and a lot else.
Here are the subjects Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) will NEVER touch:
1) Why has the company been telling us every single year since 2017 that the clinical trials are about to re-start "next year," yet next year comes and goes and the target gets pushed out one more year. And there's no explanation why, and even no explanation of the fact that this is happening!! Sorry, but this needs to be called what it is: LYING TO US.
2) Why does Calvin Wallen III's biography indicate that he has an undergraduate degree from Texas A&M that he does not have? He is a confirmed dropout with only a high school diploma. (At least that's more than can be said for Grant Gordon, who is a dropout who doesn't even have a high school diploma; he should be proud at least of having a diploma from junior high school/middle school.)
3) Why does Venturis Therapeutics/CVBT refuse to publicly release its audited financial statements? (We know the answer to this - because the statements will show the company is both insolvent and illiquid.)
4) Why has the company tried to cover up the departure of a series of executives, by refusing to issue statements explaining their departures? We've been left to figure this out ourselves. The good news, however, is that possibly some of them have privately shared the reasons for their departures.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
I suppose it doesn't matter, because the music is about to stop for good, and there will be no chairs for anyone to sit on. We are very close to the end. For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
How zombie companies like Venturis Therapeutics die
Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) has for all practical purposes been dead since 2008. But like a good zombie company, it has continued onwards pointlessly for another 13 years, trying to give every impression of viability where there is none. Zzombie….zzzombie….zzzzzzombie…….zzzzzzzzzzzzz
But even zombie companies like Venturis Therapeutics eventually die. And that death for Venturis is at hand, now that Venturis has suffered a crushing 7-figure judgment it reportedly can’t pay. Further, Venturis is facing a winning adversary that is rumored to be planning very aggressive collection efforts. Once the final judgment amount is announced by the judge arbitrator, the collection effort is likely to immediately commence.
The only question unclear to me is whether or not Venturis’s death will come from involuntary bankruptcy and liquidation, or if Venturis will file for bankruptcy itself in the onslaught of collection activities and then be liquidated (there is no revenue stream here, so liquidation is certain). One fact is clear to me: Venturis will not be able to pay the judgment. The company has been insolvent for over a decade, and according to a particular insider who left the company and spoke candidly with a shareholder who reached out to him/her, Venturis/CVBT has been out of cash for years (i.e. illiquid) and is unable to advance on anything meaningful or costly (patents are cheap, and in this case, pointless). All the absurd chatter here indicating that Venturis Therapeutics or CVBT has raised $10 million, $150 million, $2 billion, or whatever fictional number suits the moment, based on valuations that exceed Apple’s or whatever nonsense is being spouted, is pure fantasy with a strong alcoholic delusional component. Venturis has provided zero evidence that any of it has ever happened—-because it didn’t in my opinion. Indeed, CFO Robert Schleizer said at one of the annual shareholder meetings that the company had received a qualified audit from its auditors with a going concern disclaimer. Do you know what that’s called in accounting circles? The death spiral. Companies rarely recover from it. And this one won’t.
So long, farewell, auf wiedersehen, goodbye...
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
And to hear more from a Venturis insider who spilled the beans:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
It must be painful for Calvin Wallen, Grant Gordon, and the rest of the non-existent team at Venturis Therapeutics (formerly Cardiovascular Biotherapeutics) to see their lunch being eaten in broad daylight by the former CEO. I have no skin in the game for whatever Dan Montano is doing, but at least he's doing it unlike this pathetic group. So much for all the lies and broken promises from this uneducated bunch of losers that call themselves Venturis Therapeutics leadership. A less credible bunch would be impossible to find. I guess having only a high school diploma actually means something in the real world. Yes, this company is led by someone who only has a high school diploma--Calvin Wallen III. And Grant Gordon doesn't have even that! At least both share in common that they're dropout losers, so no wonder they relate so well to one another--until of course Wallen laughs at Gordon behind his back and ridicules him constantly as there have been numerous reports through the grapevine.
The countdown to the Venturis Therapeutics bankruptcy filing continues. With Venturis/CVBT losing a 7-figure judgement to Dan Montano (I still haven't heard an exact figure, but I'm sure we will soon), the only thing I'm unclear on is whether the coming bankruptcy will be voluntary or involuntary. Let's just hope that the "alleged" $150 million funding that is "rumored" on this message board (and certainly not based in any reality) takes place soon hahahaha, so Venturis/CVBT can pay off Montano and its other creditors before they likely take the kind of actions that companies don't recovery from.
Here's the current state of things:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
Question 7: What promises to CVBT/Venturis shareholders have been made by Calvin Wallen III and Grant Gordon over the years which have NOT been broken:
A) We were told $8.5 million in new money would come in once Calvin Wallen III took over CVBT, and this would get the clinical trials back on track.
B) We were told that Calvin Wallen and Grant Gordon would go back to school in the evenings and finally earn their undergraduate college degree (Wallen) and high school diploma (Gordon) by 2018, so that the company's CEO and one of its Directors could both at least say they had high school diplomas, and the CEO would at least have a college degree.
C) We were told that the clinical trials would resume in 2019.
D) We were told the company would hold annual shareholders meetings every year and communicate regularly with shareholders, unlike the previous leadership team.
E) We were told that moving the company to Dallas and integrating itself into the Dallas biotechnology ecosystem (there is one?) would jumpstart the company's progress.
(The correct answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. Unlike the cheap imitators here who lack a single original thought in their minimally-educated brains, ours is an educational and fun exercise for the whole family while we're mostly not social distancing anymore (but are going to be sorry we didn't).
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (B), these are not promises that were broken, because unlike all the other choices, (B) containts promises that were never made. Sadly, we were never told by the company's leadership that they would address their own educational deficits. Instead, the company continues to be led by dropouts who lack even a college degree. No wonder the results have been so dismal and the company's bankruptcy and shutdown is close at hand. Oh well...this just goes to show you that in order to succeed in a knowledge-based industry, you need one key thing--knowledge. These people are laughingstocks! And even among this pathetic group of laughingstocks, rumor has it that one in particular--the one with the Irish or Scottish accent (I can't place it)--is routinely ridiculed behind his back by even them! Reportedly the rest of the leadership team laugh at this poor tosser for his complete lack of education and because he's reportedly thought of as a moron as well (when sober).
Sneak preview: Next week's question is going to be a really good one!!
Question 6: Which of the following are successful achievements at Venturis Therapeutics / Cardiovascular Biotherapeutics since Calvin Wallen’s hostile takeover in 2014?
A) Venturis Therapeutics’s first drug indication was approved by the FDA.
B) The company’s stock was re-listed on the NYSE and is currently trading at record highs.
C) Grant Gordon finally earned his high school diploma and is no longer a high school dropout.
D) Venturis successfully raised $150 million from Bernie Madoff.
E) Venturis successfully raised $100 million from a consortium of North Korean investors, who insisted the company be re-named Kim Il Sung Biotechnology Corporation.
F) To address shareholder criticisms of the weak Board of Directors, Calvin Wallen III successfully recruited a McKinsey legend, Jeffrey Skilling, to join the Board.
G) Calvin Wallen and Grant Gordon were able to locate and destroy the photos of them with Jeffrey Epstein on his Caribbean island.
H) Venturis initiated a new clinical development program in Alcoholic Impotence.
I) None of the above are true – the list of meaningful achievements during Calvin Wallen’s stewardship is nearly non-existent.
(The correct answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. It's educational and fun for the whole family while we're mostly not social distancing anymore.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (I), None of the above are true. Yes, it’s pathetic, but in 7 years Venturis Therapeutics/CVBT have accomplished little other than securing a bunch of useless patents, and making false statements at its shareholder meetings--when it has actually held them (unlike, say 2020). But then again, why should anyone expect otherwise from such an unimpressive, uneducated group of chronic under-performers and under-achievers, who are credibly alleged to be led by a crook (by the U.S. government) and a drunkard (by all liquor store owners within a 20 mile radius of his residence)? But it doesn't matter, because the curtain comes down for good very soon.
Here's how "fine" Venturis Therapeutics is doing:
MAJOR NEWS: Venturis Therapeutics Insider Spills The Beans
Someone I know who's also a Venturis Therapeutics / Cardiovascular Biotherapeutics (CVBT) shareholder had a phone conversation with an individual who used to work at Venturis Therapeutics, and found out what’s really going on. It's ugly (to no surprise).
Here are the highlights:
1) The individual indicated Venturis Therapeutics is broke and has no money, and has not had any money during his/her period of involvement. The lack of resources has led to departures of several executives. (Editorial comment - this explains the constant turnover in the leadership team, which I have noted in a series of posts over the last several years.)
2) This person said that not only is there no clinical trial activity going on, there is no plan for any clinical trial activity to happen. They have not even manufactured drug. This person said all the clinical programs are dead in the water.
3) The individual indicated the whole patent strategy is an effort to give the appearance of viability, and spending money on patents is cheap compared to clinical trials. This person does not believe that any of the new patents are actually meaningful. (Editorial comment - That’s obvious to anyone who has any background in science or medicine, or has any level of education.)
4) Grant Gordon has reportedly been in and out of hospitals due to his end-stage illness, and has been written off by insiders. If Grant Gordon has been the conduit for the funding for Venturis Therapeutics as has been reported from numerous sources, what does this mean for the future if he is out of time? Nothing good.
5) This individual believes the situation at Venturis Therapeutics is hopeless. It’s why he/she left. And he/she is still owed money that he/she believes he/she will never see.
Editorial comment – None of what this individual told my friend comes as a surprise. Still, it’s useful that it’s now been confirmed by someone who was in a position to know all.
Question – How many weeks will it be before Venturis Therapeutics shuts down/files for bankruptcy? I believe we are down to weeks at this point, not years.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
Are Venturis Therapeutics and others officially in hospice yet, or it just unofficial?
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
...and make sure to read this as well:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
It has to be meaningful both to Venturis Therapeutics / Cardiovascular Biotherapeutics (CVBT) and to Grant Gordon to be able to see in advance their epitaphs.
In case you missed it, here are those epitaphs:
1) https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
2) https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156097956
Rumored huge blowup between Calvin Wallen & Grant Gordon
I’m hearing rumors that there was recently a huge blowup between Calvin Wallen III and Grant Gordon. Rumors suggest that the two came to blows over the strategic direction of Venturis Therapeutics, and it allegedly erupted into a shouting match that was heard by others. It’s all hush-hush at this point so the details are proving elusive, but the two are rumored to have clashed over the new AI indication for Venturis Therapeutics’s drug (alcoholic impotence).
The sole funding spigot for Venturis, a.k.a. Calvin Wallen III, has reportedly been shut off given the large 7-figure judgment Venturis suffered in the binding arbitration case against Dan Montano (do we have a final figure yet?). Apparently Grant Gordon was pushing hard for Venturis to announce the new alcoholic impotence indication and to prioritize the AI clinical program ahead of everything else. Mr. Wallen reportedly refused, and my sources said they heard that in anger and frustration at Grant Gordon's constant badgering, Mr. Wallen screamed at him to “stop being so f*****g selfish and fixated only on your personal problems - I've got a company to try and save!” Wallen shouted that he was not going to discuss the AI indication further unless Grant Gordon himself raised the money for this promising clinical program. Well, as everyone knows, when it comes to raising any substantial sums of money, Grant Gordon has been on a dry spell for a decade-plus (which reportedly is the only dry spell he’s been on). And Mr. Gordon himself is extremely frustrated and rumored to be very sick, which is why he is pushing so hard on this AI program - he sees it as his final legacy. Insiders have written him off at this point and believe his complete departure is only a matter of time.
I’m sure I’m not the only one hearing these rumors. What pieces of the story am I missing?
For more information about the end of this company, read here:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
Question 5: What is the name of the bankruptcy judge who oversaw Venturis Therapeutics / Cardiovascular Biotherapeutics's involuntary bankruptcy in 2018/2019, and who publicly stated that Venturis (named CVBT at the time) is unable to pay its debts as they become due?
A) Judge Judy
B) Judge Ruth Bader Ginsburg
C) Judge Wapner
D) Judge Gary Spraker
E) Judge Dredd
(The correct answer is at the bottom of this posting)
(OK, this one is easy and a bit of a respite after some of the more tricky earlier questions.)
This is part of our new Venturis Therapeutics educational trivia series. It's educational and fun for the whole family while we're all social distancing!
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (D) Judge Gary Spraker. While Venturis Therapeutics and its supporters like to pretend Judge Spraker didn't make this determination, and at every turn say "show me where he said it" (and I've previously posted the link more than once and will not do so again in response to this ridiculous trolling), the fact is that Judge Gary Spraker both determined AND stated at the involuntary bankruptcy trial that Venturis Therapeutics is unable to pay its debts as they become due. So not only is Venturis insolvent, it is also illiquid according to Judge Spraker. Way to go, Calvin & the minions!
cvbtech, thanks for an amazingly illuminating response. In just one message, you've put it out there in black and white for all to see, exactly what's wrong with Venturis Therapeutics / Cardiovascular Biotherapeutics. That is, other than Venturis Therapeutics/CVBT is insolvent, illiquid, and is about be seized by creditors and liquidated, or declare bankruptcy and be liquidated.
In response to every problem that we've all pointed out about Venturis, your answer is unvaryingly the same: Let's look backwards--it's all Dan Montano's fault! No shareholders meeting (as required) in 2020? Well, look at how few shareholders meetings Dan held! CVBT is facing a court judgement it can't pay? Well look at how many cases Dan has lost (which by the way isn't remotely true, but you're allowed your delusions). The current management team has lied to us repeatedly and is screwing up royally? Well, nothing can be worse than how Dan screwed up.
The sum total of all this company has to say about its pathetic performance is to only look back (never forwards) and say: never mind our failings and lies and broken promises and complete lack of accountability, what about what Dan did? You might have gotten away with that a year after Montano left, maybe 2, but 7 LONG YEARS? C'mon--that's just pathetic.
This company's leadership are all a bunch of incredibly stupid losers. It's exactly what you would expect of a bunch of dropouts who don't have any educations/degrees other than at best high school diplomas (i.e. Calvin Wallen III; Grant "AI" Gordon doesn't even have a high school diploma). And there is likely criminality involved as well. But we'll let the authorities settle that issue as they're very much on a pathway to doing.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
I'm sure your confidence is no doubt buoyed by the fact that Judge George Spraker stated at Venturis Therapeutics / CVBT's involuntary bankruptcy trial that Venturis/CVBT is unable to pay its debts as they become due. That's definitely anyone's idea of confidence-building information to build hope, right?
Or are you holding out hope that we will get answers at the 2020 annual shareholders meeting, which is to be held sometime in May 2020? Oops!! It's June 1 today and we've had no 2020 shareholders meeting, or word of one. And according to the company's bylaws, it is to be held in May of every year. So much for the bylaws.
As you well know since you're all but certainly someone in CVBT's leadership, the situation is hopeless--and that comes from multiple sources independent of one another. All we can do is wait for the inevitable bankruptcy filing that is coming and the liquidation of this dead company. I'm told that phone messages don't get returned already.
For more information, here are two must-reads:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155941891
MAJOR NEWS: Venturis Therapeutics Insider Spills The Beans
Someone I know who's also a Venturis Therapeutics / Cardiovascular Biotherapeutics (CVBT) shareholder had a phone conversation with an individual who used to work at Venturis Therapeutics, and found out what’s really going on. It's ugly (to no surprise).
Here are the highlights:
1) The individual indicated Venturis Therapeutics is broke and has no money, and has not had any money during his/her period of involvement. The lack of resources has led to departures of several executives. (Editorial comment - this explains the constant turnover in the leadership team, which I have noted in a series of posts over the last several years.)
2) This person said that not only is there no clinical trial activity going on, there is no plan for any clinical trial activity to happen. They have not even manufactured drug. This person said all the clinical programs are dead in the water.
3) The individual indicated the whole patent strategy is an effort to give the appearance of viability, and spending money on patents is cheap compared to clinical trials. This person does not believe that any of the new patents are actually meaningful. (Editorial comment - That’s obvious to anyone who has any background in science or medicine, or has any level of education.)
4) Grant Gordon has reportedly been in and out of hospitals due to his end-stage illness, and has been written off by insiders. (Editorial comment - That would partially explain why Venturis Therapeutics is flat broke—-in addition to insolvency, incompetent and uneducated leadership, etc.) If Grant Gordon has been the conduit for the funding for Venturis Therapeutics as has been reported from numerous sources, what does this mean for the future if he is out of time? Nothing good.
5) This individual believes the situation at Venturis Therapeutics is hopeless. It’s why he/she left. And he/she is still owed money that he/she believes he/she will never see.
Editorial comment – None of what this individual told my friend comes as a surprise. Still, it’s useful that it’s now been confirmed by someone who was in a position to know all.
Question – How many weeks will it be before Venturis Therapeutics shuts down/files for bankruptcy? I believe we are down to weeks at this point, not years.
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
Please explain why I as a Venturis/CVBT shareholder should give a damn what Dan Montano has done before or after CVBT (now named Venturis)? It's IRRELEVANT.
The only thing I care about as a Venturis Therapeutics shareholder is what Venturis's leadership is doing NOW AND GOING FORWARD.
Here's the question: What does our current leadership plan to do to save this company? (I myself believe it is beyond saving, but I'm open to listening).
STOP DEFLECTING AND ANSWER THE DAMN QUESTIONS WE THE SHAREHOLDERS ARE ASKING, VENTURIS LEADERSHIP!
Here is why I believe Venturis Leadership will continue to ignore questions asked by its shareholders:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
Question 4: Starting in what years did Venturis Therapeutics / Cardiovascular Biotherapeutics publicly indicate its clinical trials would be re-commencing after an absence of all clinical trial activity since 2007?
A) 2018
B) 2019
C) 2020
D) 2021
E) All of the above
F) A, B, and C
(The correct answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. It's educational and fun for the whole family while we're all social distancing!
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (F) 2018, 2019, and 2020. Yes, we shareholders have been publicly and very falsely told that the clinical trials would re-start in 2018, then in 2019, then in 2020….but we’ve never ONCE been told why any of those promised dates never materialized, and to this date, not a single clinical trial has been run since 2007. Rather, the stance from Calvin Wallen III and Grant Gordon has been to act as if everything is on schedule and no promises were ever made and subsequently broken. Is it possible that one of them was too drunk to even notice?
If you chose (E), the judges will still award you half a point. Unfortunately Venturis Therapeutics hasn’t yet told us that the trials will be re-starting in 2021, likely because they have not held the 2020 annual shareholders meeting as they were supposed to where we would have been told that lie. But this is a reasonable answer, so it's worth half a point.
It's telling that all Venturis Therapeutics's "supporters" (also known as its leadership) seem to only want to discuss are three things:
1) Dan Montano and the events of the past (kind of like how Trump seems to only want to discuss Obama and his "failings" rather than Trump's own disastrous response to the pandemic and his complete failure of leadership)
2) Patents, patents, patents
3) "Other people" saying how "valuable" this bankrupt and completely dead company is
What Venturis Therapeutics DOESN'T talk about are the things that actually matter:
1) Running clinical trials and the strategy here to get the clinical trials back on track after 14 years of none
2) Raising money to pay for and run such clinical trials
3) The business plan going forward.
In all my investment experience, I've never crossed paths with such a pathetic leadership group that seems capable only of excuses and blaming others but never themselves, who never address any real issues, and who 100% lack any sort of accountability. But read the textbooks on the subject--this is entirely consistent with alcoholic co-morbidity.
Speaking of alcoholic....err, accountability, where is the announcement from Venturis Therapeutics about the 2020 shareholders meeting, which was supposed to have happened by now?
(Hint - there will never be another shareholders meeting before the coming bankruptcy and liquidation.)
Here are some answers to these questions:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
"Saved Our Investment"???? Are you remotely serious?
1) Venturis/CVBT stock is not trading and hasn't been for YEARS. My brokerage account shows a value of ZERO for this stock. $0.00!
2) CVBT/Venturis has not run a SINGLE CLINICAL TRIAL since 2007. That means we're now in the 14th year without a single patient being treated. For a development stage biotech company with no approved drugs and no revenue stream, no clinical trials in 14 years means DEAD AND WORTHLESS.
3) If you think this is the definition of "saving our investment," could you please explain how you define the word "failure"?
Here is the reality: Venturis Therapeutics is DEAD. Done. Finished. Kaput. All that awaits is the final bankruptcy filing. And continued drunken rants telling us how valuable this stock actually is because of all the worthless patents, which are actually a joke to anyone who actually knows anything, but look to be worth "billions" to blithering idiots who are grossly uneducated and beyond stupid.
(The one exception is possibly the potential AI indication--Alcoholic Impotence; more to come on that so stay tuned.)
For more sober (and sobering) information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
Calvin Wallen and Grant Gordon don't even belong in any sentence that includes Bill Gates. They don't even belong in the same sentence as Bill Gates's driver and bartender (well, perhaps Grant Gordon does).
Apples and oranges nonsense, when comparing Tesla/SpaceX with Venturis Therapeutics. The Tesla and SpaceX employees without proper education are CERTAINLY NOT the CEO ot other leadership. Nice try, though!
Here's more information about the consequences of having such uneducated leadership at Venturis Therapeutics:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
Question 3: As the biotech industry is highly knowledge-based, what sort of educational degrees does Venturis Therapeutic’s top leadership have?
A) Calvin Wallen III has an Bachelor's degree from Paul Quinn College in TX, and Grant Gordon (or "AI" as his friends call him) has an Associate's degree from London South Bank University in the U.K.
B) Calvin Wallen III and "AI" Gordon are both accomplished businessmen with MBAs from top schools: Kennesaw State University (Wallen) and University of North Florida (Gordon).
C) Calvin Wallen only has a high school diploma and Grant Gordon doesn’t have even that. Both are dropouts.
D) Calvin Wallen went to dental school at University of Oklahoma where he got the idea to drill for oil instead. Grant "AI" Gordon was one of Wallen’s first patients at the free clinic because with limited income and large and growing aqua vitae expenditures, private dentists were beyond Gordon’s budget.
E) Calvin Wallen has an honorary degree from Harvard University where he was the Commencement Speaker in 1992. Grant "AI" Gordon was working as a groundskeeper on campus when he heard Wallen’s speech. The two met when Gordon was emptying a trash bin that Wallen threw his empty water bottle into.
(The correct answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. It's educational and fun for the whole family while we're all social distancing!
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (C) - both Mr. Wallen and Mr. Gordon are dropouts, with neither having even a college diploma. Mr. Gordon tries to hide that he lacks even a paltry high school diploma - it's embarrassing. (E) is a bit of a trick answer, because Mr. Gordon was actually working as a groundskeeper at East Mississippi Community College (where he also repeatedly sought admission - unsuccessfully) when he met the commencement speaker, Mr. Wallen. Unfortunately, East Mississippi Community College didn't realize until the check bounced (which led to an internal investigation that uncovered the whole fiasco) that Mr. Wallen's commencement speech about how he founded Wal-Mart was a complete fraud.
Ummm....you do not get a point for the correct answer, I'm afraid. :(
Venturis Therapeutics New Drug Indication
I've been working hard researching the new drug indication that it's rumored Venturis Therapeutics is very much pursuing - Alcoholic Impotence, or AI as many call it. Reportedly Calvin Wallen III and Grant Gordon are really jazzed on the possibiilities of Venturis Therapeutics' drug producing excellent clinical results in AI patients. For sure better treatments are needed, because alcoholics should be able to start/have families just as much as normal people can. I'm finding some fascinating information and plan to share it with you in the near future.
The problem for AI patients is that drunk sperm are uninterested in swimming to fertilize an egg, they just turn around and swim towards the bar. And in those few instances where fertilization actually occurs, usually the mother's body will spontaneously abort the fetus once it discovers it was created from drunk sperm.
Here's more information about Venturis Therapeutics:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
Question 2: What was the last year that Venturis Therapeutics ran a clinical trial?
A) 2007
B) 1973, during the oil crisis
C) 1939, on the eve of World War II
D) 1783, just after the end of the Revolutionary War
E) Venturis Therapeutics has never run a clinical trial.
(The answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. It's educational and fun for the whole family while we're all social distancing!
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (E) Venturis Therapeutics has never run a clinical trial. (Trick question!) While this company has been named Venturis Therapeutics, it has never run a clinical trial (and never will given that Venturis is on the verge of shutting down for good.) Since Calvin Wallen III's hostile takeover in 2014, Cardiovascular Biotherapeutics or CVBT, later re-named Venturis Therapeutics, has not run a single clinical trial. So much for all the money Mr. Wallen promised CVBT shareholders he would bring into the company to resume the clinical trials (and we all know what really happened - it's all Obama's fault!). The last clinical trial that ran was completed in 2007. So some might consider (A) the correct answer (OK, you get half a point if you chose A), but the truly correct answer is (E).
Correction of error (to err is human...)
My apologies, it's come to my attention that there was an error in our first Venturis Therapeutics quiz question from yesterday (copied in below).
While I indicated that the correct answer was (B) - 0 clinical trials have been run by Venturis Therapeutics in the last decade, one participant pointed out that the correct answer could also be (D), $14 million in stolen money doesn't go as far as it used to.
The judges met to consider this appeal. Here is our conclusion:
(D) could also be considered a correct answer because it implies that no clinical trials have been run in the last decade but might have if only Calvin Wallen III had stolen more than the $14 million he's been accused of stealing by the U.S. government. It was a unanimous decision - the judges agreed that (D) is also correct.
Anyone who chose (D) as a correct answer should consider that they got this right.
I apologize for the lack of clarity - we will do better with our next question, which you can look forward to soon.
Here is the original question:
Question: How many clinical trials has Venturis Therapeutics run in the last decade?
A) 16
B) 0
C) It's all about the patents, dude!
D) $14 million in stolen money doesn't go as far as it used to. (Venturis Therapeutics Chairman & CEO Calvin Wallen III is accused of stealing $14 million by the U.S. government from the company he was running prior to Venturis / CVBT, and his upcoming trial is delayed now because of the pandemic.)
(Answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. Fun for the whole family, while we're all sheltering in place!
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (B) 0
Yes, it is true, Venturis Therapeutics hasn't run a single clinical trial in over a decade. Isn't that impressive? What we have gotten instead are....oh yeah, lots of excuses.
Question: How many clinical trials has Venturis Therapeutics run in the last decade?
A) 16
B) 0
C) It's all about the patents, dude!
D) $14 million in stolen money doesn't go as far as it used to. (Venturis Therapeutics Chairman & CEO Calvin Wallen III is accused of stealing $14 million by the U.S. government from the company he was running prior to Venturis / CVBT, and his upcoming trial is delayed now because of the pandemic.)
(Answer is at the bottom of this posting)
This is part of our new Venturis Therapeutics educational trivia series. Fun for the whole family, while we're all sheltering in place!
For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827
The correct answer is: (B) 0
Yes, it is true, Venturis Therapeutics hasn't run a single clinical trial in over a decade. Isn't that impressive? What we have gotten instead are....oh yeah, lots of excuses.
Venturis Therapeutics: The End Has Arrived
Goodbye, Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT as it was called). It's been a not-so-nice ride for this shareholder who has lost 100% of his investment. With Venturis suffering a catastrophic multi-million dollar adverse judgment in favor of Dan Montano (we should be hearing the exact dollar amount soon, but it's in the many millions of dollars), I believe Venturis / CVBT is finished once and for all. I see one of two outcomes:
1) The company pays Dan Montano the full judgment--if it has the cash (and I believe Venturis doesn't - see below).
2) The company doesn't have an ability to pay the judgment and files for bankruptcy once Montano commences his collection efforts which rumors indicate are going to be highly aggressive. If Venturis Therapeutics files for bankruptcy, that may turn out to be an unwise move, because rumors are that Montano has an ability to pierce the corporate veil and is going to equally aggressively pursue the officers and directors personally.
No one should be surprised at this outcome. Venturis Therapeutics may be the new name for Cardiovascular Biotherapeutics (CVBT), but it's still the same old zombie company that has not run a single clinical trial since 2007. I believe there are many reasons why the end is now at hand. But let's be clear, this judgment is simply the straw that broke the camel's back, this ending was inevitable:
1) Insolvent: Venturis Therapeutics is insolvent, except now Venturis Therapeutics was apparently playing Enron-style accounting tricks to make it appear otherwise ("debt-free balance sheet" as some on this message board claim - ummm, right). At the 2018 shareholders meeting (which is just a year and a half ago), Venturis Therapeutics CFO Robert Schleizer stated that the company received a going concern qualification from its auditors. So what had changed since then? Well, I believe we received the answer in message #1434 from someone who reports to have the financials in his/her possession--apparently the financial statements from the auditors were compilations, not audits. A compilation is the auditor's presentation of the company's numbers on its letterhead without an audit or an opinion letter--thus, management's representations of the numbers. And in these compilations, the massive debt seemed to have just magically disappeared--amazing! (No audited financial statements had ever been released by Venturis Therapeutics / Cardiovascular Biotherapeutics (CVBT), which says it all.)
2) Illiquid: Venturis Therapeutics has been unable to pay its debts as they become due, according to bankruptcy judge Gary Spraker in 2019 (when the company was called Cardiovascular Biotherapeutics). This statement of fact was in the public record, no one needed to take my word for it. And while there is a troll(s) who kept saying there's no proof of this, I had previously posted where anyone could find Judge Spraker's conclusion. Go review my previous messages if you would like to see it for yourself, you'll find it in one of them. I promise. :)
3) Alleged crook in charge: The majority shareholder, Chairman, and President of Venturis Therapeutics, Calvin Wallen III, is an accused crook and facing a trial in 2020 (but is being delayed because of the pandemic) brought by the U.S. Government bankruptcy trustee for fraud and allegedly stealing $14 million from his previous company, Tauren Exploration Inc. Mr. Wallen, who only holds a high school diploma but likes to give the impression he has a college degree from Texas A&M that he doesn't have, has successfully delayed his day of reckoning for nearly two years, but it seems unlikely he will make it three. And Mr. Wallen has a trail of bankrupt companies to his name. Does anyone remember Cubic Energy Inc.? (and didn't Cubic Energy also have sketchy accounting behind its demise as well? could there be a pattern here?)
4) Leadership is a revolving door: In the last 18 months the company has lost its President, its Chief Medical Officer, and its Chief Science Officer. And everyone else that remains pretty much appears to be part-timers who also hold other jobs and are not even based in Dallas TX. Can anyone say, window dressing? No one viable stays on a sinking ship.
5) Dead in the water: Not one clinical trial has been run in the last 14 years by Venturis Therapeutics (and counting). The only thing that matters for a development-stage biotech company is running clinical trials, but that's not what Venturis/CVBT seemed to be doing. Instead the company talked like brain-eaten zombies about patents, patents, patents as if that's what really matters. I'd long ago put that zombie patent issue to rest repeatedly, but like a zombie subject, it never died (until it has):
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153942486
If you'd like to better understand these issues, here is more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153252377
The Continuing Lies From & About Venturis Therapeutics
All we get out of this company are lies and deceit in my opinion. Given the frequency that the name Grant Gordon pops up here (or AI as his friends call him), I'm curious how much he's involved in these lies. Let's consider:
1) Weren't we told last year that some huge Asian investment deal was imminent? (And with some new "rumored" new deal popping up here al the time that never turns out to be true, my response was to identify North Korean investors as the source of funding). Whatever happened to this incredible Asian deal? The answer - nothing, because it was fictitious from the start.
2) Where's our annual shareholders meeting in 2020? It should be happening about right now. There's been no announcement. The company has said nothing. Of course, I predicted last year that the 2019 annual meeting would be the last one ever. I'll stand on that prediction.
3) We've been told that sometime in 2019 Venturis Therapeutics (which was known as Cardiovascular Biotherapeutics or CVBT at the time) raised $10 million from investors. The company made no announcement, it was only discussed on this message board by "many" users (who all misspell in the same drunken Scottish brogue). I've searched extensively online and I can see no evidence on any VC or investor website that CVBT/Venturis is listed as anyone's investment. There are no SEC filings reflecting this. I believe this is a giant lie.
4) We've been told on this message board that some impresive industry figure was soon to come on board as the new CEO. So what happened with that? (Let me guess - he chose to instead spend more time with his family.)
5) We're told by Venturis that the outcome of the arbitration with Dan Montano was inconsequential. That's an outright lie--Venturis LOST. Big time. The damages will be in the millions, and we should have a hard number that is undeniable by the end of the month. Yet still on this message board it is claimed that the damages are insignificant. That's a complete lie. But we don't need to debate this, because we will have a number soon. It is in the 7-figures. Unless Venturis Therapeutics can write a check to Dan Montano in that amount, it's GAME OVER.
There are many more examples of Venturis Therapeutics lies that I could post (for example, the statements made by management at the shareholders meetings, none of which have come true such as the timelines for clinical trials re-starting, all of which have come and gone and nothing has changed--this company hasn't run a single clinical trial since 2007), but the point is clear: Through their actions, Venturis Therapeutics leadership has shown that it is fundamentally dishonest. But that's no secret to anyone that has paid attention to Calvin Wallen III and Grant Gordon. The former is accused of stealing $14 million from his last company, Tauren Exploration Inc., and is going to go on trial once the courts re-open. The latter has been accused on here of stealing money from investors, and what's interesting is that there have been no responses on this subject from anyone associated with Venturis or from Grant "AI" Gordon himself. That's curious in and of itself, when someone is making such serious accusations:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155615444
But it really doesn't matter anyway, because I believe the curtain comes down for good very soon. Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
Venturis Therapeutics: The End Has Arrived, Part 2
Rumor is we'll know by the end of May 2020 exactly how many millions of dollars have been awarded to Dan Montano in damages by the arbitrator/judge in the binding arbitration case which Venturis Therapeutics / CVBT lost. Which is why we're seeing so much nastiness being thrown around (anonymously) on this message board towards Dan Montano. If any of it is true, why didn't Venturis have the balls to say this stuff in front of the judge instead of anonymously here?
Like Trump who can't own up to his own massive failures and gross incompetence (which we measure in the increasing body count), Calvin Wallen III, Grant Gordon (or AI as his friends call him), and Mickael Flaa can't own up to their own dishonesty, gross incompetence, unbelievable stupidity, probable criminality, and disgusting greed, if court records are to be believed.
It doesn't matter - as soon as courts resume normal business and the collection/liquidation effort against Venturis Therapeutics goes full bore, the curtain will fall once and for all on this zombie company, and on us long-suffering shareholders who will have paid the ultimate price here. And you can be sure once that happens, one drunken tosser (if his liver hasn't completely failed by that point) will still be publicly posting messages somewhere under many different usernames talking to "each other" in turn about how much higher the valuation has gone. But we've seen this movie before, and it's called "Affliction" (1997).
For those just tuning in, here's the current situation:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
SCAM ALERT: On the eve of Venturis going out of business after suffering a catastrophic, multi-million dollar judgement at the hands of Dan Montano that it likely can not pay short of liquidation (and the liquidation proceeds won't come close to covering the judgment), and the nonsense press release about provisional patent filings related to the coronavirus pandemic (intended to make this insolvent company appear attractive to uninformed individuals), it appears someone on this message board is trying to get others to buy shares of Venturis Therapeutics stock at "discounted" prices. Everyone should be mindful that Venturis is a de-listed, insolvent, illiquid, and all-but-bankrupt company that hasn't run a single clinical trial since 2007 (and was called Cardiovascular Biotherapeutics or CVBT while its stock was trading before it was de-listed). If I'm reading these postings correctly, such transactions somehow involve Grant Gordon. Is Grant Gordon directly involved in this shady scheme? I have my own opinion, informed by messages #1943 & #2023.
BEWARE!
Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
One other comment about Venturis Therapeutics' AI indication (alcoholic impotence). This is an incredible opportunity, not just domestically but internationally as well. In certain countries such as Scotland, Grantestrin could easily become one of the top 3 best selling drugs. I need to check with the World Health Organization, but I believe Scotland has one of the highest rates of AI in the world.
Venturis Therapeutics Pursuing AI Indication For Its Drug
We should have more discussion about Venturis Therapeutics (formerly Cardiovascular Biotherapeutics or CVBT) pursuing a new indication to treat AI – alcoholic impotence. For men who have been alcoholics for many decades, they often find themselves unable to make babies in the first place. Drunk sperm are uninterested in swimming to fertilize an egg, they just turn around and swim towards the bar. And in those few instances where fertilization actually occurs, usually the mother's body will spontaneously abort the fetus once it discovers it was created from drunk sperm.
Rumors coming out of Venturis Therapeutics are that Calvin Wallen and Grant Gordon have been really burning the midnight oil on this one, because they believe that AI (alcoholic impotence) may be treatable with Venturis's drug. How? By bringing new blood to the testicles, many more sperm will be created, and hopefully some of them will be healthier than the drunk sperm pickled by the alcoholic’s binge drinking. (The rumor is Venturis is thinking of naming the drug Grantestrin)
This is a very exciting line of clinical pursuit. I’m going to publicly commit that when Venturis announces the AI (alcoholic impotence) clinical program being cleared by the FDA, I will purchase more Venturis stock, regardless of the price. And I’m willing to bet Venturis has already filed patents on this exciting new indication. It’s even more brilliant than the erectile dysfunction indication Venturis has obtained patents for!
(Let's give credit where credit is due--to Calvin Wallen III and Grant Gordon, who between the two of them have one high school diploma and no college degrees. Who would have thought that erectile dysfunction, a problem of blood pressure, could be resolved by increasing the blood supply? That's what's wrong with Ph.D.'s--they know too goddamn much for their own good. It sometimes takes uneducated people to come up with such a stroke of genius!)
Another consequence of decades-long alcoholism eventually leading to full impotence is that before patients reach that terrible outcome, they may cause pregnancy in their spouse but during pregnancy eventually the mother's immune system understands that drunk sperm have fertilized the egg and the first words out of the baby's mouth will be "get me a Bloody Mary." Once the immune system realizes this, it causes the body to induce a spontaneous abortion, a.k.a. miscarriage.
Isn't there reason to believe that Venturis Therapeutics' drug could treat this condition? It seems as viable as Venturis's erectile dysfunction clinical program, so why not?
For more information about Venturis Therapeutics, take a look at this:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
Alcoholic Psychosis 101, cvbtech's message cleanly proves the case. Venturis Therapeutics really needs to look into treating this condition. And they'd quickly have their first patient to sign up for the clinical trial.
Let's see....would I rather trust VT/CVBT with a successful millionaire businessman minus a college degree or an educated, corrupt, bankrupt, conman? The answer is SOOOO obvious even conman Dan would agree!
Could Venturis Therapeutics's drug could be used to treat or cure impotence brought on by decades of out-of-control alcoholic consumption day after day, week after week, year after year, a.k.a. chronic alcoholism, which makes it impossible for these men to father children? Drunk sperm cells aren't able to find ovaries, they just instead naturally swim in the other direction to try and get to the bar. Could Venturis's drug change that?
Shouldn't Venturis Therapeutics file a patent on this? It would be as meaningful as their erectile dysfunction patents and frankly the rest of their patent portfolio. I suspect that when Venturis is liquidated, no one is going to have even the slightest interest in their "valuable" patents. There's not one useful one in the lot. So why not add another from this new clinical development program that has North Koreans investors so excited?
Oh, I forgot...companies on the verge of shutting down for good/bankruptcy that haven't run a single clinical trial since 2007 are not about to start a new clinical development program, North Korean-funded or not. And the reportedly stolen money from Tauren Explortaion which it's rumored has funded Venturis Therapeutics aka Cardiovascular Biotherapeutics (CVBT) these past few years has run out. Could Calvin Wallen III find more money to steal from somewhere else?
Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
It's interesting that Venturis' two top people, Calvin Wallen and Grant Gordon, only have high school educations. Calvin Wallen has just a high school diploma, and Grant Gordon doesn't have even that--I understand Mr. Gordon dropped out of high school. To his credit, Mr. Wallen at least dropped out of college.
Can anyone think of any other biotech company, public, private, or de-listed, that is led by such uneducated people as these? Is it any wonder the results at Venturis have been so dismal?
Fore more information on the current dismal state of Venturis Therapeutics:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989
SCAM ALERT: On the eve of Venturis going out of business after suffering a catastrophic, multi-million dollar judgement at the hands of Dan Montano that it likely can not pay short of liquidation (and the liquidation proceeds won't come close to covering the judgment), and the nonsense press release about provisional patent filings related to the coronavirus pandemic (intended to make this insolvent company appear attractive to uninformed victims), it appears someone on this message board is trying to get others to buy shares of Venturis Therapeutics stock at "discounted" prices (formerly, Cardiovascular Biotherapeutics or CVBT when the company's shares were publicly trading). Everyone should be mindful that Venturis is a de-listed, insolvent, illiquid, and all-but-bankrupt company that hasn't run a single clinical trial since 2007. If I'm reading these postings correctly, such transactions somehow involve Grant Gordon. Is Grant Gordon directly involved in this shady scheme? I have my own opinion, informed by Message #1943.
BEWARE!
Here's more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155218989